Concepedia

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Monique J. Roobol, Melissa Kerkhof, Fritz H. Schröder, Jack Cuzick, Peter Sasieni, Matti Hakama, Ulf‐Håkan Stenman, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski,

European Urology · 2009 · 216 citations · 8 references

DOI

Concepts

References

8

Screening and Prostate-Cancer Mortality in a Randomized European Study

Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · New England Journal of Medicine · 2009 · 4K citations · Full text

, , +14

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

Gerrit Draisma, Rob Boer, Suzie J. Otto et al. · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

, , +16

ADJUSTING FOR NON-COMPLIANCE AND CONTAMINATION IN RANDOMIZED CLINICAL TRIALS

Jack Cuzick, Robert R. Edwards, Nereo Segnan · Statistics in Medicine · 1997 · 307 citations

, , +14

Correcting for Non-Compliance Bias in Case–Control Studies to Evaluate Cancer Screening Programmes

Stephen W. Duffy, Jack Cuzick, Làszló Tabár et al. · Journal of the Royal Statistical Society Series C (Applied Statistics) · 2002 · 123 citations · Full text

, , +17

Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

Suzie J. Otto, Ingrid W van der Cruijsen, Michael Liem et al. · International Journal of Cancer · 2003 · 84 citations · Full text

, , +12